Peter Crosby has an undergraduate degree in Electrical Engineering and a Graduate Degree in Biomedical Engineering. He is an inventor on over 50 US patents (and foreign equivalents). After working for 15 years in Research and Development, he served as CEO of six medical device companies (public and private) in four countries. Extensive international experience.
He has brought many products from concept to market release through clinical trials and regulatory approval. He is well versed in FDA, CE Mark, and Australian TGA approval or clearance process.
He has served on the board of directors of 13 companies (public and private) including chairman of the board, and qualified as a Fellow of the Australian Insititue of Company Directors.
He has raised capital for many companies, and taken one company public. He has negotiated or participated in several M&A agreements.
Medical device domain experience includes implantable devices (cochlear implants, cardiac pacemakers, implantable defibrillators, LVAD (artificial heart), neurostimulation), medical imaging (ultrasound), software (including artificial intelligence), in vitro diagnostics, patient monitoring, and on-line education.
Clinical domain experience includes cardiology, cardiac surgery, otolaryngology, orthopedics, pain management, radiology, clinical pathology, gastroenterology, and ophthalmology.
Mr. Crosby has served as an expert witness in many cases, including writing reports (and rebuttal reports), depositions, and trial appearance. He has worked in intellectual property including patents (infringement, validity, IPR, ITC, ownership) and alleged misappropriation of trade secrets; product liability; contract disputes (especially M&A contracts and "commercially reasonable efforts"), corporate governance and fiduciary duty; among others.
